Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Oriola

0.77 EUR-1.29 %13.11. klo 18.29
7,758 following

ORIOLA

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-1.29 %
+3.51 %
-15.25 %
-13.82 %
-33.30 %
-33.77 %
-19.52 %
-61.94 %
-58.30 %

Oriola is a pharmaceutical group with a particular focus on the distribution of pharmaceuticals to other players in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest operations are in the Nordic and Baltic regions. The headquarters are located in Espoo.

Read more
Market cap
142.14M EUR
Turnover
55.93K EUR
P/E (adj.) (26e)
EV/EBIT (adj.) (26e)
P/B (26e)
EV/S (26e)
Dividend yield-% (26e)
Coverage
Recommendation
Reduce
Target price
Updated
29.10.2026
Disclaimer
Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Forum discussions
It is now high time to replace the skipper, and at the AGM, overhaul the entire board. The company has basically been destroyed in just over ten years, and next year they’ll be asking the owners for more money once the ERP project and the Järvenpää logistics center fail. In my opinion...
11/11/2026, 5:11 PM
11
These releases from Oriola feel like busywork. Now heads have been appointed to three existing business areas!
11/10/2026, 7:49 AM
7
Oriola is shaking up its organizational model again, just a couple of years after the previous change. Now, the joint sales organization is being dismantled and the company will be divided into three units: Distribution, Wholesale, and Expert Services. In practice, the previous Services...
11/10/2026, 7:33 AM
by Rauli_Juva
6
Rauli has published a new company report on Oriola following Q3 :)\n\n> Oriola’s Q3 results were in line with our expectations, and the joint venture Kronans’ earnings improved significantly. Our forecasts remained practically unchanged, and we still see a risk of a guidance cut....
10/29/2026, 8:09 PM
by Sijoittaja-alokas
6
Inderes Sisäpiiritieto, tulosvaroitus: Oriola muuttaa vuoden 2026 näkymiään - Inderes Oriola Oyj Pörssitiedote, sisäpiiritieto 11.11.2026 klo 18.15Sisäpiiritieto, tulosvaroitus: Oriola muuttaa vuoden 2026 näkymiäänOriola Oyj muuttaa vuoden 2026 näkymiään. Neljännen vuosineljä... ...
11/11/2026, 4:24 PM
by Montau
5
Here are Rauli’s comments on Oriola’s Q3 results Oriola’s Q3 report was operationally broadly in line with our expectations, and adjusted EBITDA remained stable despite an unexpected inventory write-down. Below the operating profit level, the joint venture Kronans Apotek improved...
10/29/2026, 8:54 AM
by Sijoittaja-alokas
5
Here are Rauli’s preview comments ahead of Oriola’s earnings report on Thursday We expect the company’s revenue to grow moderately, but earnings to remain virtually on par with the comparison period, weighed down by higher costs. In our view, reaching the full-year guidance will ...
10/27/2026, 6:53 AM
by Sijoittaja-alokas
5
Read more on our forum
Rauli Juva
Rauli Juva

Analyst

Latest research

Latest analysis report

Released: 05.10.2026

Latest extensive report

Released: 23.06.2026

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
23.2.
2027

Annual report '26

24.3.
2027

General meeting '27

29.4.
2027

Interim report Q1'27

Regulatory press release16.11.2026 klo 08.30

Inside information: Oriola Corporation CEO Katarina Gabrielson resigns

Oriola
Regulatory press release11.11.2026 klo 18.15

Inside information, profit warning: Oriola revises its outlook for 2026

Oriola
Press release10.11.2026 klo 09.15

Oriola Oyj: Oriola plans to revise its operating model to strengthen commercial ownership and support transformation

Oriola

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Oriola Q3’26: Kronans Apotek showing positive development (eng.)6:12
Video29.10.2026 klo 14.24
by Pia Maljanen

Oriola Q3’26: Kronans Apotek showing positive development (eng.)

Oriola’s Q3 was broadly solid quarter. However, profitability remained at the comparison period’s level, weighed down by a one-off inventory impairment. On a positive note, Kronans Apotek continued to make progress towards improved performance.

Oriola
Oriola, Webcast, Q3'26
Webcast29.10.2026 klo 10.00

Oriola, Webcast, Q3'26

Oriola
Regulatory press release29.10.2026 klo 08.30

Oriola Oyj: Oriola Corporation's Interim Report 1 January-30 September 2026

Oriola
Press release15.10.2026 klo 09.00

Oriola Oyj: Oriola Corporation to publish its Interim Report for January-September 2026 on 29 October 2026

Oriola
Oriola: Risks weigh on the coming years
Research05.10.2026 klo 08.34
by Rauli Juva

Oriola: Risks weigh on the coming years

The prolonged IT system renewal means that, in our view, a sustainable earnings improvement will only be possible by 2029.

Oriola
Press release01.10.2026 klo 08.30

Oriola Oyj: Oriola updates timeline and investment of ERP and warehouse management programme

Oriola
Regulatory press release24.09.2026 klo 12.15

Correction: Oriola Corporation: Notification of a change in shareholding according to Chapter 9, Section 10 of the Securities Market Act

Oriola
Regulatory press release23.09.2026 klo 17.00

Oriola Corporation: Notification of a change in shareholding according to Chapter 9, Section 10 of the Securities Market Act

Oriola
Regulatory press release18.09.2026 klo 09.00

Oriola Oyj: Oriola has corrected previously reported financial information

Oriola
Regulatory press release17.09.2026 klo 09.00

Oriola Oyj: Publication schedule for Oriola Corporation's financial reporting in 2027

Oriola
Oriola Q2'26: Headwinds from higher freight costs6:42
Video17.07.2026 klo 12.42
by Rauli Juva

Oriola Q2'26: Headwinds from higher freight costs

Higher freight costs and increased operating expenses weighed on Oriola's earnings in Q2. Meanwhile, associate company Kronans improved its result compared with the corresponding period last year.

Oriola
Oriola, Webcast, Q2'26
Webcast17.07.2026 klo 10.00

Oriola, Webcast, Q2'26

Oriola
Regulatory press release17.07.2026 klo 08.30

Oriola Oyj: Oriola Corporation's Half-Year Report 1 January-30 June 2026

Oriola
Press release03.07.2026 klo 09.00

Oriola Oyj: Oriola Corporation to publish its Half-Year Report for January-June 2026 on 17 July 2026

Oriola
Oriola Extensive Report: Patience prescribed
Extensive research23.06.2026 klo 12.15
by Rauli Juva

Oriola Extensive Report: Patience prescribed

Oriola's stock looks cheap, but there are clear risks associated with both the balance sheet and operational activities.

Oriola
Regulatory press release12.06.2026 klo 17.00

Oriola Oyj: Oriola's share buyback programme has been completed

Oriola
Regulatory press release10.06.2026 klo 19.00

Oriola Oyj: Acquisition of own shares during week 24, 2026

Oriola